185 related articles for article (PubMed ID: 19220820)
1. Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model.
Gaines AR; Lee-Stroka H; Byrne K; Scott DE; Uhl L; Lazarus E; Stroncek DF
Transfusion; 2009 Jun; 49(6):1050-8. PubMed ID: 19220820
[TBL] [Abstract][Full Text] [Related]
2. Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia.
Levendoglu-Tugal O; Jayabose S
J Pediatr Hematol Oncol; 2001 Oct; 23(7):460-3. PubMed ID: 11878583
[TBL] [Abstract][Full Text] [Related]
3. What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura?
Garratty G
Transfusion; 2009 Jun; 49(6):1026-31. PubMed ID: 19638151
[No Abstract] [Full Text] [Related]
4. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
Chun NS; Savani B; Seder RH; Taplin ME
Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
[TBL] [Abstract][Full Text] [Related]
5. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.
Gaines AR
Blood; 2000 Apr; 95(8):2523-9. PubMed ID: 10753830
[TBL] [Abstract][Full Text] [Related]
6. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura.
Gaines AR
Blood; 2005 Sep; 106(5):1532-7. PubMed ID: 15878975
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Rh immune globulin for treating immune thrombocytopenic purpura.
Sandler SG
Curr Opin Hematol; 2001 Nov; 8(6):417-20. PubMed ID: 11604585
[TBL] [Abstract][Full Text] [Related]
8. Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin.
Winiecki S; Baer B; Chege W; Jankosky C; Mintz P; Baker M; Woodworth T; Nguyen M
Transfusion; 2015 Jul; 55 Suppl 2():S28-35. PubMed ID: 26174895
[TBL] [Abstract][Full Text] [Related]
9. A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP).
Tarantino MD; Bussel JB; Cines DB; McCrae KR; Gernsheimer T; Liebman HA; Wong WY; Kulkarni R; Grabowski E; McMillan R
Blood; 2007 Jun; 109(12):5527; author reply 5528. PubMed ID: 17554071
[No Abstract] [Full Text] [Related]
10. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
Alioglu B; Avci Z; Ozyurek E; Ozbek N
J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
[TBL] [Abstract][Full Text] [Related]
11. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin.
Rushin J; Rumsey DH; Ewing CA; Sandler SG
Transfusion; 2000 May; 40(5):551-4. PubMed ID: 10827257
[TBL] [Abstract][Full Text] [Related]
12. Severe hemolysis following administration of Rh(o)(D) immune globulin in an ITP patient associated with anti-C.
Schwartz J; Spitalnik S; Grima KM
Blood; 2006 Mar; 107(6):2585. PubMed ID: 16517982
[No Abstract] [Full Text] [Related]
13. Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura.
Kees-Folts D; Abt AB; Domen RE; Freiberg AS
Pediatr Nephrol; 2002 Feb; 17(2):91-6. PubMed ID: 11875670
[TBL] [Abstract][Full Text] [Related]
14. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
Rewald MD; Francischetti MM
Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
[TBL] [Abstract][Full Text] [Related]
15. Acute hemolysis of transfused A2 red cells by an auto-HI antibody.
Darabi K; Makar RS
Transfusion; 2008 May; 48(5):964-8. PubMed ID: 18454737
[TBL] [Abstract][Full Text] [Related]
16. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.
Rubinstein PG; Chen YH
Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323
[No Abstract] [Full Text] [Related]
17. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
Freiberg A; Mauger D
Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
[TBL] [Abstract][Full Text] [Related]
18. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
Front Immunol; 2021; 12():698541. PubMed ID: 35003054
[TBL] [Abstract][Full Text] [Related]
19. The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis.
Allhorn M; Briceño JG; Baudino L; Lood C; Olsson ML; Izui S; Collin M
Blood; 2010 Jun; 115(24):5080-8. PubMed ID: 20357243
[TBL] [Abstract][Full Text] [Related]
20. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
Moser AM; Shalev H; Kapelushnik J
Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
